Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Shares, $0.01 par value
-
Shares outstanding
-
28,862,386
-
Total 13F shares
-
5,495,691
-
Share change
-
+277,964
-
Total reported value
-
$74,402,090
-
Price per share
-
$13.54
-
Number of holders
-
78
-
Value change
-
+$3,747,676
-
Number of buys
-
42
-
Number of sells
-
27
Institutional Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q2 2023
As of 30 Jun 2023 abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) had 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 5,495,691 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, 1607 Capital Partners, LLC, Allspring Global Investments Holdings, LLC, NEEDHAM INVESTMENT MANAGEMENT LLC, Cornerstone Advisors, LLC, WOLVERINE ASSET MANAGEMENT LLC, FLAGSHIP HARBOR ADVISORS, LLC, RPO LLC, LAZARD ASSET MANAGEMENT LLC, and RAYMOND JAMES & ASSOCIATES.
This table shows 78 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.